Biotech Business
Stem Cell Sciences In-Licenses Breakthrough Discovery for the Production of Human Stem Cells (''Stem Cell Sciences'', ''SCS'' RIG
Published in Biotech Law Weekly, July 6th, 2007
Stem Cell Sciences plc (SCS) (AIM:STEM) (ASX:STC), the global biotechnology company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce the exclusive in-licensing of a breakthrough technology. This is expected to significantly accelerate the application of human embryonic stem (ES) cells in both research and cell-based therapies. This discovery overcomes the key challenge in the effective scale-up of stem cell technologies - cell death. When separated from one another, during transfer from one growth vessel to another in routine laboratory processes such as scale-up and genetic modification, human ES cells commonly undergo cell death. The use...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2007-07-06)
More Articles from Biotech Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Closes $40 Million Common Stock Offering; Underwriters Exercise Full over-Allotment Option - AARP
Leading New York Physician Calls on Legislature to Pass Rx Gift Disclosure Legislation - AARP
Senior Advocates Join to Say 'No Way' to 'No-Growth' Budget - Acusphere, Inc.
Acusphere Announces Closing of Common Stock and Warrant Offering - Alliance of Specialty Medicine
Nation's Medical Specialists Applaud House Action to Establish Clear and Valid Approach to Physician Reporting on Quality Measures - America's Second Harvest-The Nation's Food Bank Network
House Subcommittee Markup Provides Hope for Millions of Hungry Americans - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
